Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Tax Rate (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Tax Rate for 14 consecutive years, with 12.56% as the latest value for Q4 2025.

  • Quarterly Tax Rate fell 1277.0% to 12.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18.2% through Dec 2025, up 158.0% year-over-year, with the annual reading at 18.22% for FY2025, 161.0% up from the prior year.
  • Tax Rate hit 12.56% in Q4 2025 for Ani Pharmaceuticals, down from 21.3% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 37.63% in Q3 2021 to a low of 21.96% in Q4 2023.
  • Historically, Tax Rate has averaged 17.22% across 5 years, with a median of 21.89% in 2021.
  • Biggest five-year swings in Tax Rate: skyrocketed 62652bps in 2021 and later plummeted -4772bps in 2023.
  • Year by year, Tax Rate stood at 21.89% in 2021, then rose by 18bps to 25.76% in 2022, then plummeted by -185bps to 21.96% in 2023, then soared by 215bps to 25.33% in 2024, then plummeted by -50bps to 12.56% in 2025.
  • Business Quant data shows Tax Rate for ANIP at 12.56% in Q4 2025, 21.3% in Q3 2025, and 18.77% in Q2 2025.